Cargando…

Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber

INTRODUCTION: Secondary analysis of hospital-hosted clinical data can save time and cost compared with prospective clinical trials for neuroimaging biomarker development. We present such a study for Sturge-Weber syndrome (SWS), a rare neurovascular disorder that affects 1 in 20 000–50 000 newborns....

Descripción completa

Detalles Bibliográficos
Autores principales: Vedmurthy, Pooja, Pinto, Anna L R, Lin, Doris D M, Comi, Anne M, Ou, Yangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819809/
https://www.ncbi.nlm.nih.gov/pubmed/35121603
http://dx.doi.org/10.1136/bmjopen-2021-053103
_version_ 1784646126885928960
author Vedmurthy, Pooja
Pinto, Anna L R
Lin, Doris D M
Comi, Anne M
Ou, Yangming
author_facet Vedmurthy, Pooja
Pinto, Anna L R
Lin, Doris D M
Comi, Anne M
Ou, Yangming
author_sort Vedmurthy, Pooja
collection PubMed
description INTRODUCTION: Secondary analysis of hospital-hosted clinical data can save time and cost compared with prospective clinical trials for neuroimaging biomarker development. We present such a study for Sturge-Weber syndrome (SWS), a rare neurovascular disorder that affects 1 in 20 000–50 000 newborns. Children with SWS are at risk for developing neurocognitive deficit by school age. A critical period for early intervention is before 2 years of age, but early diagnostic and prognostic biomarkers are lacking. We aim to retrospectively mine clinical data for SWS at two national centres to develop presymptomatic biomarkers. METHODS AND ANALYSIS: We will retrospectively collect clinical, MRI and neurocognitive outcome data for patients with SWS who underwent brain MRI before 2 years of age at two national SWS care centres. Expert review of clinical records and MRI quality control will be used to refine the cohort. The merged multisite data will be used to develop algorithms for abnormality detection, lesion-symptom mapping to identify neural substrate and machine learning to predict individual outcomes (presence or absence of seizures) by 2 years of age. Presymptomatic treatment in 0–2 years and before seizure onset may delay or prevent the onset of seizures by 2 years of age, and thereby improve neurocognitive outcomes. The proposed work, if successful, will be one of the largest and most comprehensive multisite databases for the presymptomatic phase of this rare disease. ETHICS AND DISSEMINATION: This study involves human participants and was approved by Boston Children’s Hospital Institutional Review Board: IRB-P00014482 and IRB-P00025916 Johns Hopkins School of Medicine Institutional Review Board: NA_00043846. Participants gave informed consent to participate in the study before taking part. The Institutional Review Boards at Kennedy Krieger Institute and Boston Children’s Hospital approval have been obtained at each site to retrospectively study this data. Results will be disseminated by presentations, publication and sharing of algorithms generated.
format Online
Article
Text
id pubmed-8819809
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88198092022-02-08 Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber Vedmurthy, Pooja Pinto, Anna L R Lin, Doris D M Comi, Anne M Ou, Yangming BMJ Open Neurology INTRODUCTION: Secondary analysis of hospital-hosted clinical data can save time and cost compared with prospective clinical trials for neuroimaging biomarker development. We present such a study for Sturge-Weber syndrome (SWS), a rare neurovascular disorder that affects 1 in 20 000–50 000 newborns. Children with SWS are at risk for developing neurocognitive deficit by school age. A critical period for early intervention is before 2 years of age, but early diagnostic and prognostic biomarkers are lacking. We aim to retrospectively mine clinical data for SWS at two national centres to develop presymptomatic biomarkers. METHODS AND ANALYSIS: We will retrospectively collect clinical, MRI and neurocognitive outcome data for patients with SWS who underwent brain MRI before 2 years of age at two national SWS care centres. Expert review of clinical records and MRI quality control will be used to refine the cohort. The merged multisite data will be used to develop algorithms for abnormality detection, lesion-symptom mapping to identify neural substrate and machine learning to predict individual outcomes (presence or absence of seizures) by 2 years of age. Presymptomatic treatment in 0–2 years and before seizure onset may delay or prevent the onset of seizures by 2 years of age, and thereby improve neurocognitive outcomes. The proposed work, if successful, will be one of the largest and most comprehensive multisite databases for the presymptomatic phase of this rare disease. ETHICS AND DISSEMINATION: This study involves human participants and was approved by Boston Children’s Hospital Institutional Review Board: IRB-P00014482 and IRB-P00025916 Johns Hopkins School of Medicine Institutional Review Board: NA_00043846. Participants gave informed consent to participate in the study before taking part. The Institutional Review Boards at Kennedy Krieger Institute and Boston Children’s Hospital approval have been obtained at each site to retrospectively study this data. Results will be disseminated by presentations, publication and sharing of algorithms generated. BMJ Publishing Group 2022-02-04 /pmc/articles/PMC8819809/ /pubmed/35121603 http://dx.doi.org/10.1136/bmjopen-2021-053103 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Neurology
Vedmurthy, Pooja
Pinto, Anna L R
Lin, Doris D M
Comi, Anne M
Ou, Yangming
Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber
title Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber
title_full Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber
title_fullStr Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber
title_full_unstemmed Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber
title_short Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber
title_sort study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with sturge-weber
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819809/
https://www.ncbi.nlm.nih.gov/pubmed/35121603
http://dx.doi.org/10.1136/bmjopen-2021-053103
work_keys_str_mv AT vedmurthypooja studyprotocolretrospectivelyminingmultisiteclinicaldatatopresymptomaticallypredictseizureonsetforindividualpatientswithsturgeweber
AT pintoannalr studyprotocolretrospectivelyminingmultisiteclinicaldatatopresymptomaticallypredictseizureonsetforindividualpatientswithsturgeweber
AT lindorisdm studyprotocolretrospectivelyminingmultisiteclinicaldatatopresymptomaticallypredictseizureonsetforindividualpatientswithsturgeweber
AT comiannem studyprotocolretrospectivelyminingmultisiteclinicaldatatopresymptomaticallypredictseizureonsetforindividualpatientswithsturgeweber
AT ouyangming studyprotocolretrospectivelyminingmultisiteclinicaldatatopresymptomaticallypredictseizureonsetforindividualpatientswithsturgeweber
AT studyprotocolretrospectivelyminingmultisiteclinicaldatatopresymptomaticallypredictseizureonsetforindividualpatientswithsturgeweber